{
    "id": "dtop3vb5a2gz2w3qkxmsz2tyebj4t2dz",
    "title": "Cancer: A Computational Disease that AI Can Cure",
    "info": {
        "author": [
            "Jay M. Tenenbaum, CollabRx, Inc."
        ],
        "published": "Sept. 1, 2010",
        "recorded": "July 2010",
        "category": [
            "Top->Computer Science->Artificial Intelligence"
        ]
    },
    "url": "http://videolectures.net/aaai2010_tenenbaum_cac/",
    "segmentation": [
        [
            "It's sad and truly an honor to accept an award in the name of my friend and colleague Bob Inglemoor."
        ],
        [
            "Bob from 1985 until his retirement, can I get the volume up slightly higher?",
            "From 1985 till his retirement in 1998, ran an extraordinary laboratory which really pioneered applications of AI to bio medicine.",
            "And although I've never worked in the Knowledge Systems Lab and Stanford, it's alumni, it's projects.",
            "Technologies and the progeny institutions continue to inspire and inform me to this very day."
        ],
        [
            "I'm going to talk about cancer today from my unique perspective as an AI researcher and Internet entrepreneur and Cancer Survivor.",
            "I'm going to talk about begin with a report from the front and what Gina Kolata of the New York Times called the 40 years war.",
            "Unfortunately things are not going very well.",
            "I'm then going to talk about a new paradigm.",
            "Actually a guerrilla war that some of us are trying to wage with the objective of trying to cure cancer one patient at a time.",
            "Which is a lot easier because cancer is just a very heterogeneous disease.",
            "There are probably hundreds if not thousands of variations of cancer.",
            "It's much easier to try to cure one person and generalize from what you've learned.",
            "And finally, we're going to talk about the many, many opportunities to apply AI to meeting the challenges and opportunities of curing cancer.",
            "Some of these things can be done today with these tools, and some of them are required deep research.",
            "And one thing I learned that slumber J was the best.",
            "Research is the kind that you do when you have a hard problem.",
            "It's very important to solve, but you don't know how to do it with today's tools.",
            "And so when you're done.",
            "You not only have great iresearch, but you don't have to worry about, but it's good for it, you know.",
            "So.",
            "That's one of the most important lessons I learned in research and I shared with you today."
        ],
        [
            "So despite 100 billion dollars and 40 years of time, things aren't going so well.",
            "We haven't made much of a dent in the mortality of cancer, which is completely frustrating when you look at it against these other killer diseases where major progress has been made.",
            "It's not that nothing has been accomplished.",
            "100 billion dollars for cancer together with the like sum that was put into the Human Genome Project.",
            "Is.",
            "Gotten us a tremendous increase in our knowledge of cancer.",
            "The biology of cancer, the mechanisms of action of drugs.",
            "We have some amazing new cancer drugs.",
            "The breakdown is happened in the translation of that research to the clinic.",
            "So lots of experiments are tried every day by oncologists.",
            "And basically we captured none of that.",
            "Learning to 1st order.",
            "And Secondly, there's this Grand Canyon of a Gulf that exists between the research and the.",
            "Clinical communities, and so when something is is found that could shed light on either verifying or refuting a research hypothesis, we never get to do that.",
            "So there's a real issue.",
            "The opportunity is, though, that the genome project, together with breakthroughs in computational and systems biology.",
            "Long ways towards turning biology into an information science.",
            "Which is very very good for those of us in this room who do information science.",
            "And it's very important to me personally, because for me this war is personal."
        ],
        [
            "In 1998 I was diagnosed with metastatic Melanoma, which is a wicked disease.",
            "Med students learn that in medical school, the one thing to remember about Melanoma is don't get it.",
            "And the median survival is quite quite short.",
            "There were no drugs effective drugs in the pipeline.",
            "The time to develop a new drug is 15 years in a billion dollars.",
            "I didn't have that much time or money and So what to do?"
        ],
        [
            "What to do is what every newly diagnosed cancer patient does.",
            "You go running around two different oncologists trying to hear something that you like and what I learned was I went to five different oncologists and got five different opinions and if I listen to any of them I probably would not be here today but I but I actually had a lucky break.",
            "This is when people talk about what goes around comes around.",
            "I was doing some pro bono consulting for Rick Klausner who at the time happened to be running the National Cancer Institute.",
            "And I said Rick, I need some help and he put me in touch with the with the top researchers who were developing Melanoma therapeutics and and these guys had some very very much more interesting offerings.",
            "But none of them could tell me which one was best for me.",
            "And that was the challenge.",
            "That's where the guesswork comes in."
        ],
        [
            "What I wanted, like any good AI researcher would want, is that at each point in my cancer journey, to be able to have all of the world's knowledge and resources together with the decision tools to be able to make the optimal decision.",
            "And then because I'm public minded, I would like to capture the outcomes, good or bad, and at each stage so that they were there to improve the decisions for the next patient coming along.",
            "In the end though, I had to make a gut call and I put my bet my life."
        ],
        [
            "On a clinical trial that failed.",
            "And what's what's interesting about this is the whole notion of clinical trials, which the entire drug industry relies on to develop drugs.",
            "It's very expensive, very time consuming.",
            "It's where a lot of those 15 years ago."
        ],
        [
            "But the problem with clinical trials in a disease like cancer, which as I said is very heterogeneous, is that when you recruit 100 or 1000 patients for a trial, you're really dealing with the fruit cocktail of diseases and so when a drug you know works on 40% of patients, another drug works on 10% of the patients is the 40% drug better for you?",
            "Well, not necessarily.",
            "It depends whether you're more similar to the 10% of the patients or the 40%.",
            "Another serious problem is that many, many trials fell because they only helped one or two people.",
            "So come on, what disease did we cure that these people have that we've cured?",
            "And these learnings are typically lost, so this is another opportunity to ask ourselves.",
            "You know, maybe we've already cured 20 percent, 50% of cancer?",
            "Who knows?",
            "We just don't know it yet.",
            "And I want to ask a question which I'm going to repeat several times today.",
            "Do you think a little AI can help on this kind of problem in connecting people excuse me, results to the people who need them.",
            "That's that's where I think we can make a contribution."
        ],
        [
            "When I talked about we have much more knowledge about cancer.",
            "Today, we understand concert cancer to fairly deep level in terms of interactomes of jeans with other genes with proteins, proteins with proteins.",
            "We have signaling diagrams such as this one.",
            "Much of what we know is probably wrong or incomplete, but we know things and here's a couple of cancer pathways that are responsible for a large number of melanomas.",
            "And I'm on the left.",
            "The yellow pathway is a map kinase pathway.",
            "It's the one that makes the gas pedal stick on so.",
            "The cells proliferate and on the left my left and my right right.",
            "Here is the PI3 pathway in blue which is a brake pedal supposed to make the cells either rest of the cell cycle or destroy themselves if they're going out of control.",
            "The BRAF pathway gene at the top of the map kinase pathway is implicated in about 60 or 65% of melanomas, and just recently there's been a drug that's been developed for it.",
            "So we can, in a very targeted way, find the mutation and hit it and it'll arrest those cancers.",
            "They'll melt away.",
            "The problem is that cancer is smart and it will find ways compens, atory mechanisms, and then you know some of the surviving clones.",
            "Pi 3K might might mutate, so take the brakes off and we've got to hit that too.",
            "Unfortunately, there's just now a drug that's coming into trials for being able to do that, so the ability to be able to analyze cancer at this causal level.",
            "And be able to place bets by taking drugs and then capture the learnings and use that not just to treat the patient but to be able to improve our understanding of whether this causal model is right is the."
        ],
        [
            "Breakthrough and leads us to the possibility of trying to treat cancer to win the war on cancer in a different way, which is 1 patient at a time."
        ],
        [
            "So the basic idea is to do what I wanted to do for me to be able to take for each patient, take all of the knowledge and resources in the world, and try to understand what it is that's the best possible treatment for that patient at that moment in time.",
            "Then apply the patient, apply the treatment, and see how the patient does and capture the learnings not just over that patient, but overall patients in order to drive the field forward in general.",
            "So that's the paradigm, and here's basically how it works.",
            "I think about this is taking the 15 years in the billion dollars and shrinking that down to the time and dollars that individual patient might have."
        ],
        [
            "So if we're going to take 15 years and shrink it down to a month or two, we're going to have to make not incremental improvements, but major.",
            "You know, slices, slashes to this timeline then."
        ],
        [
            "1st is to get rid of clinical trials because they really don't make sense in heterogeneous diseases like cancer."
        ],
        [
            "Replace them with deep genomic analysis of individual patients tumors."
        ],
        [
            "And then the second thing we're going to have to do is to.",
            "We don't have time to develop new drugs, so we're going to have to work with the drugs that we that we have on hand.",
            "But that's actually a much bigger space than it appears.",
            "There are 5000 drugs that have been approved by the FDA and similar organizations around the world.",
            "Not to mention the investigational agents that are currently in trial."
        ],
        [
            "And many of these drugs we only are, we don't even have the vaguest idea what the mechanisms of action are for those drugs.",
            "Even aspirin, right?",
            "We're continuing to find new uses for it, so the probabilities are pretty good that if we apply computational and systems biology."
        ],
        [
            "Define the match."
        ],
        [
            "For that patient, against some drugs in our in our Armor Atom either used as intended or used off label or used in cocktails."
        ],
        [
            "And then when we find something that works, we can test it on other patients and see how many others it works for."
        ],
        [
            "And ultimately find subclasses of patients who respond to particular therapies.",
            "So we have the blue patients and the green patients.",
            "They respond to their respective colored pills, and that's what we're trying to do."
        ],
        [
            "Someday we'll have it all mapped out.",
            "Will have what are called treatment guidelines, which are basically a decision tree where a patient comes in, gets their tumor tested, and depending on the particular mutations that they have, can get treated with the right drugs.",
            "Unfortunately, there's a large part of the space which is currently unpopulated, unexplored, and that's the opportunity that we have and the challenge that we have is to fill out that space one patient at a time."
        ],
        [
            "So I'm going to next talk about how we're doing that, and there are other people who are doing this.",
            "I'm going to 1st talk about collaborative one which is a personalized oncology research service that I started with my colleagues, mainly Raffaelle era collaborates.",
            "And then I'm going to talk about Cancer Commons, which is a rapid learning community, the goal of which is to be able to capture the learnings from every cancer patient in order to be able to rapidly drive the field."
        ],
        [
            "So collaborates one starts with the patient and their doctor patient goes in and gets a biopsy or surgery and we have some tumor specimens.",
            "We want to apply deep by genomic analysis, and I'm talking about genome wide snip, copy number, expression analysis, even sequencing, which is becoming the prices are imploding right?",
            "It used to cost $1,000,000 five.",
            "$100,000 is 5 years ago $50,000.",
            "Today, $5000 next year, I mean the world isn't even recognizing what's happening on the imploding price curve.",
            "We've got to be ready for that.",
            "Get the deep analysis of the tumor.",
            "Do the analysis at the level of the wiring diagram that I talked about earlier.",
            "Make a recommendation for that patient feedback in a report to the Doctor and then it either works or it doesn't work.",
            "If it doesn't work, we have a new data point and it's not a data point in a mouse.",
            "It's not even one data point, it's thousands of data points from this genome wide analysis.",
            "Go back and try to understand now more about that that space that."
        ],
        [
            "Wasn't filled in, and of course doing this over multiple patients gives us a chance to really analyze and understand and do learning.",
            "So the interesting questions of course occur with the outliers, but one or two patients who responded when no one else did.",
            "Again, what disease did these patients have that we've already cured or the patients who didn't respond to go back to the scientists on whose recommendations we based the treatment plan in the 1st place and ask what did you not understand about?",
            "But disease, or about the mechanism of action of the drugs in order to have led to this result, and what can you now learn from the new data that we have?",
            "The result of all this learning, we're trying to capture in a reference model, which is basically a way to populate out this tree that I showed you the reference model."
        ],
        [
            "Here's a picture of reference model for Melanoma.",
            "As it stands today, there are a set of subtypes of Melanoma, each of which corresponds to a mutation or a combination of mutations tying back to the pathways, and each of these subtypes are actionable in the sense that there exists a clear an essay in a Cle approved laboratory that can be used to determine if a patient is in or out of that subtype, and at least one rational therapy that could be applied.",
            "These don't have to be proved in clinical trials by no means, but there has to be.",
            "Rational argument, that said, if the patient has this biology, this drug gotta work.",
            "And then the goal is to do some some carefully planned experiments, namely patients.",
            "Come in.",
            "We find out what subtype there in we give them one of the approved therapies.",
            "We captured the learnings.",
            "Some patients are going to respond, some won't, and that's going to inevitably lead to splitting those subtypes.",
            "So this list that you see here is the seed list that was created by talking to a lot of experts and then doing a meta analysis of the research literature in the data.",
            "And there are 10 of them.",
            "In fact, the bottom one has already dropped off.",
            "There's only nine, but I I'm pretty sure in a year or two we're going to have 20 or 30 or 40.",
            "I don't know how many and the interesting thing is that some of those subtypes are going to look a lot like subtypes in other cancers that are not Melanoma.",
            "And that's where we're going to be able to get the the cross learn."
        ],
        [
            "To happen.",
            "So I'm now going to talk about Cancer Commons, which is a grand experiment to be able to take the learnings from collaborate one and everyone else is working in personalized oncology, which is a field that is really beginning to take off.",
            "It's at the very, very kind of leading edge of the innovation curve and."
        ],
        [
            "Basically, the goal is in this rapid learning community to give each patient the best possible treatment for them at this moment in time, capture the learnings, analyze them, try to do.",
            "Incorporate those learnings back into the into the causal models and try to drive the field forward in this way.",
            "So cancer Commons is not only that community, but a platform for real time translation.",
            "ULL research and cancer on which this community can collaborate with each other and the community.",
            "Includes importantly, not just doctors and researchers, but patients and all of the ecosystem of service providers that are needed in order to be able to get them to do this guerrilla war.",
            "This aggressive style of end of 1 research."
        ],
        [
            "The Cancer Commons platform is lives in the cloud.",
            "It's very scalable and we've used it for building communities at many different scales, all of which are connected.",
            "So if used it first to implement collaborates one, the service I just talked about and the important thing there is that this is a completely virtual service in the sense that I don't have any laboratories.",
            "The closest thing I have is a lab is my kitchen, but we do outsource everything to different service providers in that ecosystem.",
            "This.",
            "He speaks of my ecommerce background."
        ],
        [
            "We've also used it to cook together a community of researchers who were involved in helping to develop the Melanoma reference model, and we're now putting collaborative one together with this reference model so that we can use the reference model to guide the initial treatment of patients and then when patients don't respond to take their specimens and put it through the very same research process that was used to capture the model in the first place."
        ],
        [
            "We are now hoping to move forward and use this same platform to connect many groups, like the group that was involved in creating the initial reference model in order to be able to explore different combinations of Melanoma therapies.",
            "Different combinations of investigational agents which are in trial which is truly revolutionary because drug companies traditionally have not allowed their drugs in trial to be tested in combination, but like aids, it's often the case that these therapies won't work as monotherapies.",
            "They have to be used in combination, so we're trying to put together a community built on the Cancer Commons platform so that when a patient comes in, they will get routed to the trial.",
            "That's most likely to help them, and similarly, the trial will have patients that will be most likely to inform.",
            "So this is actually quite revolutionary.",
            "And then one step up from this, the entire Melanoma community is."
        ],
        [
            "Is simply one node on cancer Commons, and so we have similar communities that we're planning to build for other cancers, and these will all be connected.",
            "And the interesting thing is that there are many, many opportunities are already emerging to be able to demonstrate the cross learnings between these communities.",
            "So, for example, there's a drug called Gleevec, which was a wonder drug for a certain type of leukemia, chronic myelogenous leukemia.",
            "But basically made that disease something one could live with for a very long time.",
            "It turned out that 3% of melanomas expressed a mutation that that drug happened to hit.",
            "Who would have guessed.",
            "Similarly, the drug that I talked about, the B RAF inhibitor, and that I was talking about earlier for Melanoma may be applicable to the 7% of colorectal cancers that Express B RAF mutations.",
            "We don't know that yet, and there are many, many mutations that are shared across the solid tumors.",
            "In the GI tract and the long so this is an opportunity to do the kind of cross learning that requires the kind of thinking and applications that we can do in this Community.",
            "So that's cancer Commons."
        ],
        [
            "And I would now like to talk about the AI opportunities and challenges."
        ],
        [
            "So re framing things from an AI perspective.",
            "What we're talking about is a gigantic search over the opportunity space of targets and leads, and that search is guided by knowledge.",
            "Alot of knowledge about cancer, biology about drugs about clinical response tests, assays.",
            "All of those things.",
            "The problem is that the knowledge is largely uncertain.",
            "Still, is large gaps in the knowledge.",
            "Complete, uncertain, much of it is no doubt wrong.",
            "And So what we have to do is use the experiments on patients ethical experiments.",
            "Remember 'cause every patient has to get the best treatment for them personally, but to gradually start to fill in these gaps."
        ],
        [
            "By doing adaptive planning to be able to look at the questions that we're trying to answer and then go back and try to use patients in an ethical way to run these experiments, capture, learn."
        ],
        [
            "Things use the learnings to infer what we can about the causal nature of cancer and the mechanisms of action of the drugs, and then generalize from each patient."
        ],
        [
            "Many other patients in order to be able to drive the field forward.",
            "Now, of course, there's much too big a gap between patients and the knowledge ball over there, so we've got to have intermediate levels of learning."
        ],
        [
            "And of course, we've talked about one so far, which is the reference model, which is a very nice, crisp, adaptive problem where the goal is to be able to continually improve prediction."
        ],
        [
            "But there are many, many, many other levels of knowledge, and these are some of the levels that are involved in the collaborative.",
            "One process.",
            "For those of you in the back pathway analysis mechanism of analysis, what do these pathways have to do with particular known cancer mechanisms?",
            "Using that to identify targets, drugs, picking clinical trials, and so forth?",
            "And we've got learning to do on every one of these levels every day with every patient."
        ],
        [
            "So the generalization is basically that each level generates hypothesis that can be then used that can then be tested at the next level down, as is traditional in a hierarchical learning system, and I think that hierarchical Bayes is a very nice way to formulate this problem because all the knowledge is probabilistic at every single level."
        ],
        [
            "So in the time remaining, I'm going to focus on some specific challenges for and opportunities and challenges for this community in three areas.",
            "Knowledge management, hierarchical planning and learning, and generalization.",
            "1st in terms of now."
        ],
        [
            "Image management I've already said that cancer curing cancer, treating cancer involves a lot of knowledge, and these are.",
            "There's a very small fraction of the knowledge that's available just on the Internet and I want to give you a scale, an idea for the scale of this knowledge Pub Med, which is major resource from the National Library of Medicine, has 20,000,000 abstracts of medical literature in it.",
            "About 3 million of those who specifically about cancer.",
            "But the answers don't necessarily come from that.",
            "The answers may come from, for example, literature on metabolism, because cancer screws up all kinds of processes within cells, and if they may provide the clue about how to do introduction, the gene expression omnibus is a public database of gene expression data.",
            "There is 450,000.",
            "Experiments that are documented, their gene expression, and sometimes the clinical annotation that goes with them.",
            "That was last time I looked a few days ago, this grows by hundreds of experiments daily.",
            "Clinicaltrials.gov has nearly 100,000 trials ongoing at any moment in time.",
            "And about 40% of those are cancer.",
            "And ASCO is where the cancer trials American Society of clinical oncology.",
            "It's a conference, much like this one, just larger where the trials get reported each year.",
            "And this is truly the front lines.",
            "And I want to."
        ],
        [
            "You are a report from the front lines of ASCO a month ago.",
            "I went to ASCO 2010, which is in Chicago.",
            "There are 30,000 people at that conference.",
            "The plenary Hall is at least as long as this one and at least as wide.",
            "It's the biggest room I've ever seen.",
            "It's not like a sports stadium where you can actually see the players in the back of the room.",
            "You can see a pinpoint of the guy up in the front giving the talk and then hundreds of screens scattered through the room.",
            "So you gotta have a visceral understanding.",
            "So 20 ring.",
            "Circus 4000 abstracts are presented in four days, of which about six of them make the plenary, so those are.",
            "Those are the ones that are considered practice changing and those are the ones you can read about in the New York Times.",
            "But there are 500 or 1000 others that might be lifesaving for some patient.",
            "If there was only a way to be able to get that information and put it in front of the patient and dock at the right time.",
            "So I'll ask my question again, do you think a little AI can help?"
        ],
        [
            "There's another issue that comes up.",
            "We talked about a few slides ago.",
            "I said there was this drug for leukemia that helped 3% of.",
            "Melanoma patients it took nearly two decades to be able to take that knowledge and transfer it and then be able to connect the dots to be able to figure that out.",
            "So the result that said Gleevec has major response for Melanoma patients who express AC kit mutation was published.",
            "I believe in 1998 by in 2008 by a friend of mine Steven Hoodie, but in 1991, Ruth Alabama, who was a pioneering AI researcher, sequencing things by hand.",
            "Figured out that seek it was a mutation that drove some small number of melanomas.",
            "She did that work at Yell, so that was 1991 in 1998.",
            "Excuse me.",
            "A group run, run, run by Brian Druker created a drug at the time it was called SDI.",
            "471 I believe drug that was later to become Gleevec.",
            "Was designed to address a particular a different mutation that was called.",
            "It was a Fusion gene that happened when two pieces or chromosome broke off and came together and created an uncle Gene, a gene that causes cancer.",
            "And this drug was very effective against that Fusion gene, so there's nothing Ruth, Alabama could do.",
            "In 1991, there was no drug.",
            "There's nothing anyone can do.",
            "In 1998 there was a drug for this Fusion gene called BCR ABL.",
            "But then in 2000 or thereabouts Druker the same group working in a different cancer, gastrointestinal stromal tumors discovered that this drug for some reason happened to also bind to and inhibit seek it.",
            "Well, there was still some dots to be connected because it wasn't till three years later the group in Italy inspired by a letter to the editor and an obscure Italian Journal that no one had ever seen.",
            "That said, you know, maybe we should try Gleevec on the Melanomas Express ticket.",
            "He connected a few dots in his head and so that led to the work that Stephen Hodi finally published in 2008 at ASCO.",
            "So nearly two decades went."
        ],
        [
            "Bye to connect three dots.",
            "Now this is something if you're serendipitous enough, you overhear something in that cocktail lounge or something that the conference science works this way, but it is unacceptable for it to work this way in cancer.",
            "There are too many lives at stake, and it's easy enough to connect 3."
        ],
        [
            "That's, but this is the size of the knowledge base that we're dealing with.",
            "These happen to be some of the databases that people involved in the Semantic Web project are trying to connect up, and the ones and magenta.",
            "Here are the ones specifically relevant to this project that I'm trying to do, and as I said, just one of them.",
            "Pub Med has 20,000,000 abstracts in it.",
            "So we need some AI here."
        ],
        [
            "It's not that hard to do some capture some low hanging fruit here.",
            "Back in 2003, Alan Rappaport Gov, who did a company called Neuron Data, which some of you may remember from earlier days and I was at Carnegie Student and I had a different company called Medstory put together a simple application for ASCO."
        ],
        [
            "In which we got people submitting abstracts in breast cancer to fill out a form something like this, which is akin to the reference model.",
            "What subtype of breast cancer were there?",
            "And there are only three subtypes.",
            "Back then, there wasn't very complicated, but based on the author filling this out.",
            "Then when I researcher or doctor came in and said what trials are relevant to my patient instead of having to thumb through 4000 pages of Bible paper, you know one page per 4004 thousand abstracts.",
            "They could look it up, and this was we actually ran a clinical trial and whether people would use this.",
            "And 95% of the authors voluntarily filled this out when they were submitting the application.",
            "In 70% of people looking up trials used it because they felt it would be helpful.",
            "This is a big success and I'm basically building on this now.",
            "For as the human interface the user into."
        ],
        [
            "Base for cancer Commons.",
            "So if you can imagine just adding some buttons to the side of this where you fill out whatever it is about your patient and then click a button and be."
        ],
        [
            "Able to find out what the treatment guidelines aren't wearing that big decision tree.",
            "You should be not looking through these decision trees themselves can run 200 pages or more."
        ],
        [
            "Or what clinical trials are available?",
            "I don't mean going through all the clinical trials, finding the clinical trials that are best for that patient."
        ],
        [
            "Or because the information is computational, once you've captured it in that.",
            "In that form you know what subtype the cancer has.",
            "We can build little applications like this, which is a mock up of an application that we're building for the launch of Cancer Commons, which will be in a month or so.",
            "By the way you heard about it here first, in which you click in the mutations that the patient has, and it gives you precisely the right trials for that patient.",
            "So simple stuff from an AI perspective, but very, very in."
        ],
        [
            "Portent so the challenge for this community is to organize the world's knowledge of cancer, biology and therapeutics and make it useful for the people who need it.",
            "Challenge one."
        ],
        [
            "The second area we're going to talk about is planning and we've talked about that a little bit and already.",
            "But the key is that there are two types of planning.",
            "The first is treatment planning for an individual, and there the goal is first of all to find something that will work for that patient to make sure that you get enough shots on goal in the hockey sense, because giving a patient one treatment may disqualify them for a second trial, for example.",
            "So you want to look at all the possibility space for that patient given the best possible shot.",
            "For where they are and what's available that moment in time, and then when you start getting into combination therapies, things get more tricky because you have to deal with what order the therapies are given in with dosing and so forth.",
            "So it's an interesting little planning problem subject to some real world constraints about how much time the patient has, how much specimen you have to work with, how much dollars you have to do, tests you always do more tests, but they are often limited in practice.",
            "And the second type of planning puts the bigger context around this of as a research field.",
            "What hypothesis do we need to validate we have different models of how to treat cancer in different drugs for each of those models, and we need to be able to learn from the ethical experiments that we're running on patients in order to be able to drive this learning.",
            "And I want to give you a sense about the possibilities for what can be done if there was a way to coordinate planning over a research field.",
            "Now I don't know that there is such a way.",
            "Except in limited contexts, where there's a Funding Agency who kind of will insist on it because doctors will go and do what they should do what they want to do for each patient.",
            "But if there were."
        ],
        [
            "Away again thinking about cancer as a giant search the way things are done today is that individual CYA."
        ],
        [
            "This pursue, you know.",
            "Interesting opportunities as they see them and they too often reach dead ends and then they don't publish them because there was nothing positive to report.",
            "So other people are doomed to keep repeating that and then they go off and start exploring somewhere else.",
            "But suppose there was a way to coordinate the research so that we could look at an entire family of."
        ],
        [
            "If Lee targets and leads and basically say, let's do."
        ],
        [
            "Prove them all at once so we can wipe out a whole part of that tree.",
            "And now let's turn things on its head like we were talking."
        ],
        [
            "To start with the patient and wipe out all the things that are not relevant to that patient now."
        ],
        [
            "We have a planning problem which is cut down the size.",
            "That's the opportunity that I would like to think about how to do research planning coordinated with treatment planning.",
            "For those of you interested in hierarchical planning, you can find him more."
        ],
        [
            "Very interesting and challenging problem.",
            "So my second challenge is to be able to adaptively plan thousands of individual treatment experiments while maximizing the learnings from them for the uncertainties that you have in your model.",
            "Now, as I've already mentioned, that the ability to be able to tell oncologists that they should be using this or that is somewhat limited, and so for every planned experiment that when does there's going to be hundreds if not thousands of other experiments that we just need a way to be able to capture the serendipitous learnings from those."
        ],
        [
            "And so the third area is learning and.",
            "There are basically two types of models that we're dealing with.",
            "The first very simple predictive models which may be statistical or maybe causal, but the reference model that I talked about is an example and the 2nd is deeper.",
            "Causal models of tumors and drugs, and there are some very interesting work going on in the machine learning statistical AI communities for doing that, and we want to put these together in the way."
        ],
        [
            "Is that I talked about, so we've talked a lot about the reference model already taking the subtypes and splitting them.",
            "I'm not going to say more about."
        ],
        [
            "That, but when we talked about the levels of knowledge in.",
            "Collaborates one way to think about this is that we want to be able to learn over all of these levels.",
            "What's happening in an individual patient based on all of the knowledge that we have about cancer in general and about drugs in general and put together.",
            "If you like the best possible linkage among all of these levels in terms of probability of cure that connects the actual measurements from the thousands of data points that we're capturing to what pathways we believe are active to what mechanisms we think they're driving.",
            "What's the best targets?",
            "The treatments?",
            "What are the clinical trials?",
            "Put those all together and then if it works or doesn't work to be able to go back and be able to drive learning at every single one of these levels."
        ],
        [
            "Which brings me to my third challenge.",
            "For those of you involved in learning, this is what it's about to be able to capture and integrate what we learn from every single patient in order to be able to drive our knowledge and then generalize so we can help as many other patients as possible."
        ],
        [
            "Which brings me to the end of the story.",
            "We've talked about cancer from the perspective of an AI researcher, Internet entrepreneur and Survivor.",
            "We've talked about a new paradigm where the goal is to be able to cure cancer one patient at a time, and we've talked about opportunities and challenges for using AI in order to be able to drive this work for much of the 40 years of the war on cancer, the AI community has been driven by grand challenges, none more prominent than chess.",
            "And I would like to propose a new grand challenge.",
            "Hopefully not for the next 40 years.",
            "How about for the next 5?"
        ],
        [
            "Here's, which is to kick cancers.",
            "You know what?",
            "The.",
            "Cancer is a lot harder than chess and so many ways to begin with it requires we have incomplete knowledge with the game, requires a lot of knowledge.",
            "Much of what we know is incomplete or wrong, and so we've got to fix that.",
            "So for all of you who are interesting, interested in knowledge management, I have given you your challenges.",
            "We've got to be able to plan thousands of adaptive experiments, except many of these experiments that will give you optimal knowledge about the uncertainties or either unethical.",
            "Or you can't do them because you can't get the drugs to do them, which really makes me sad 'cause the pharma companies won't give him to us or you don't have control over what the docs do or they're just not might be any patients available to test.",
            "You know particular things.",
            "Integrating learning well.",
            "Can.",
            "Cancer is a very widely opponent, and so if you learn something, unlike in chess cancers, quite capable of.",
            "Changing the rules on you and developing new mutations that you didn't know about, so you gotta deal with that too.",
            "And finally, there are no grandmasters and cancer, unlike chess, you play with cancer, you're going to lose most of the time so.",
            "I, I think that cancer Commons presents a unique opportunity by putting researchers, patients, and physicians on the same platform to be able to capture an extraordinary amount of data and try to close that translation a loop in real time.",
            "I really need your help.",
            "I'm saying this very, very sincerely if you're looking for a good place to do applications of AI or even basic research in AI, because some of that's needed here."
        ],
        [
            "Please get in touch with me.",
            "JMT at collaborative.com and you know, I can.",
            "I can if you want some one more incentive, unlike cancer.",
            "Excuse me, I'm like chess.",
            "Cancer has the NIH, which puts a billion dollars a year into trying to cure it.",
            "And there are 10,000,000 lives at stake.",
            "Let's go, let's go.",
            "Do some good thank you very very much."
        ]
    ],
    "summarization": {
        "clip_0": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "It's sad and truly an honor to accept an award in the name of my friend and colleague Bob Inglemoor.",
                    "label": 0
                }
            ]
        },
        "clip_1": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Bob from 1985 until his retirement, can I get the volume up slightly higher?",
                    "label": 0
                },
                {
                    "sent": "From 1985 till his retirement in 1998, ran an extraordinary laboratory which really pioneered applications of AI to bio medicine.",
                    "label": 0
                },
                {
                    "sent": "And although I've never worked in the Knowledge Systems Lab and Stanford, it's alumni, it's projects.",
                    "label": 0
                },
                {
                    "sent": "Technologies and the progeny institutions continue to inspire and inform me to this very day.",
                    "label": 0
                }
            ]
        },
        "clip_2": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "I'm going to talk about cancer today from my unique perspective as an AI researcher and Internet entrepreneur and Cancer Survivor.",
                    "label": 0
                },
                {
                    "sent": "I'm going to talk about begin with a report from the front and what Gina Kolata of the New York Times called the 40 years war.",
                    "label": 0
                },
                {
                    "sent": "Unfortunately things are not going very well.",
                    "label": 0
                },
                {
                    "sent": "I'm then going to talk about a new paradigm.",
                    "label": 1
                },
                {
                    "sent": "Actually a guerrilla war that some of us are trying to wage with the objective of trying to cure cancer one patient at a time.",
                    "label": 0
                },
                {
                    "sent": "Which is a lot easier because cancer is just a very heterogeneous disease.",
                    "label": 0
                },
                {
                    "sent": "There are probably hundreds if not thousands of variations of cancer.",
                    "label": 0
                },
                {
                    "sent": "It's much easier to try to cure one person and generalize from what you've learned.",
                    "label": 0
                },
                {
                    "sent": "And finally, we're going to talk about the many, many opportunities to apply AI to meeting the challenges and opportunities of curing cancer.",
                    "label": 0
                },
                {
                    "sent": "Some of these things can be done today with these tools, and some of them are required deep research.",
                    "label": 0
                },
                {
                    "sent": "And one thing I learned that slumber J was the best.",
                    "label": 0
                },
                {
                    "sent": "Research is the kind that you do when you have a hard problem.",
                    "label": 0
                },
                {
                    "sent": "It's very important to solve, but you don't know how to do it with today's tools.",
                    "label": 0
                },
                {
                    "sent": "And so when you're done.",
                    "label": 0
                },
                {
                    "sent": "You not only have great iresearch, but you don't have to worry about, but it's good for it, you know.",
                    "label": 0
                },
                {
                    "sent": "So.",
                    "label": 0
                },
                {
                    "sent": "That's one of the most important lessons I learned in research and I shared with you today.",
                    "label": 0
                }
            ]
        },
        "clip_3": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "So despite 100 billion dollars and 40 years of time, things aren't going so well.",
                    "label": 0
                },
                {
                    "sent": "We haven't made much of a dent in the mortality of cancer, which is completely frustrating when you look at it against these other killer diseases where major progress has been made.",
                    "label": 0
                },
                {
                    "sent": "It's not that nothing has been accomplished.",
                    "label": 0
                },
                {
                    "sent": "100 billion dollars for cancer together with the like sum that was put into the Human Genome Project.",
                    "label": 0
                },
                {
                    "sent": "Is.",
                    "label": 0
                },
                {
                    "sent": "Gotten us a tremendous increase in our knowledge of cancer.",
                    "label": 0
                },
                {
                    "sent": "The biology of cancer, the mechanisms of action of drugs.",
                    "label": 0
                },
                {
                    "sent": "We have some amazing new cancer drugs.",
                    "label": 0
                },
                {
                    "sent": "The breakdown is happened in the translation of that research to the clinic.",
                    "label": 0
                },
                {
                    "sent": "So lots of experiments are tried every day by oncologists.",
                    "label": 0
                },
                {
                    "sent": "And basically we captured none of that.",
                    "label": 0
                },
                {
                    "sent": "Learning to 1st order.",
                    "label": 0
                },
                {
                    "sent": "And Secondly, there's this Grand Canyon of a Gulf that exists between the research and the.",
                    "label": 0
                },
                {
                    "sent": "Clinical communities, and so when something is is found that could shed light on either verifying or refuting a research hypothesis, we never get to do that.",
                    "label": 0
                },
                {
                    "sent": "So there's a real issue.",
                    "label": 0
                },
                {
                    "sent": "The opportunity is, though, that the genome project, together with breakthroughs in computational and systems biology.",
                    "label": 0
                },
                {
                    "sent": "Long ways towards turning biology into an information science.",
                    "label": 0
                },
                {
                    "sent": "Which is very very good for those of us in this room who do information science.",
                    "label": 0
                },
                {
                    "sent": "And it's very important to me personally, because for me this war is personal.",
                    "label": 0
                }
            ]
        },
        "clip_4": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "In 1998 I was diagnosed with metastatic Melanoma, which is a wicked disease.",
                    "label": 1
                },
                {
                    "sent": "Med students learn that in medical school, the one thing to remember about Melanoma is don't get it.",
                    "label": 0
                },
                {
                    "sent": "And the median survival is quite quite short.",
                    "label": 1
                },
                {
                    "sent": "There were no drugs effective drugs in the pipeline.",
                    "label": 0
                },
                {
                    "sent": "The time to develop a new drug is 15 years in a billion dollars.",
                    "label": 0
                },
                {
                    "sent": "I didn't have that much time or money and So what to do?",
                    "label": 0
                }
            ]
        },
        "clip_5": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "What to do is what every newly diagnosed cancer patient does.",
                    "label": 0
                },
                {
                    "sent": "You go running around two different oncologists trying to hear something that you like and what I learned was I went to five different oncologists and got five different opinions and if I listen to any of them I probably would not be here today but I but I actually had a lucky break.",
                    "label": 0
                },
                {
                    "sent": "This is when people talk about what goes around comes around.",
                    "label": 0
                },
                {
                    "sent": "I was doing some pro bono consulting for Rick Klausner who at the time happened to be running the National Cancer Institute.",
                    "label": 0
                },
                {
                    "sent": "And I said Rick, I need some help and he put me in touch with the with the top researchers who were developing Melanoma therapeutics and and these guys had some very very much more interesting offerings.",
                    "label": 0
                },
                {
                    "sent": "But none of them could tell me which one was best for me.",
                    "label": 0
                },
                {
                    "sent": "And that was the challenge.",
                    "label": 0
                },
                {
                    "sent": "That's where the guesswork comes in.",
                    "label": 0
                }
            ]
        },
        "clip_6": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "What I wanted, like any good AI researcher would want, is that at each point in my cancer journey, to be able to have all of the world's knowledge and resources together with the decision tools to be able to make the optimal decision.",
                    "label": 0
                },
                {
                    "sent": "And then because I'm public minded, I would like to capture the outcomes, good or bad, and at each stage so that they were there to improve the decisions for the next patient coming along.",
                    "label": 0
                },
                {
                    "sent": "In the end though, I had to make a gut call and I put my bet my life.",
                    "label": 0
                }
            ]
        },
        "clip_7": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "On a clinical trial that failed.",
                    "label": 0
                },
                {
                    "sent": "And what's what's interesting about this is the whole notion of clinical trials, which the entire drug industry relies on to develop drugs.",
                    "label": 0
                },
                {
                    "sent": "It's very expensive, very time consuming.",
                    "label": 0
                },
                {
                    "sent": "It's where a lot of those 15 years ago.",
                    "label": 0
                }
            ]
        },
        "clip_8": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "But the problem with clinical trials in a disease like cancer, which as I said is very heterogeneous, is that when you recruit 100 or 1000 patients for a trial, you're really dealing with the fruit cocktail of diseases and so when a drug you know works on 40% of patients, another drug works on 10% of the patients is the 40% drug better for you?",
                    "label": 0
                },
                {
                    "sent": "Well, not necessarily.",
                    "label": 0
                },
                {
                    "sent": "It depends whether you're more similar to the 10% of the patients or the 40%.",
                    "label": 0
                },
                {
                    "sent": "Another serious problem is that many, many trials fell because they only helped one or two people.",
                    "label": 0
                },
                {
                    "sent": "So come on, what disease did we cure that these people have that we've cured?",
                    "label": 0
                },
                {
                    "sent": "And these learnings are typically lost, so this is another opportunity to ask ourselves.",
                    "label": 0
                },
                {
                    "sent": "You know, maybe we've already cured 20 percent, 50% of cancer?",
                    "label": 0
                },
                {
                    "sent": "Who knows?",
                    "label": 0
                },
                {
                    "sent": "We just don't know it yet.",
                    "label": 0
                },
                {
                    "sent": "And I want to ask a question which I'm going to repeat several times today.",
                    "label": 0
                },
                {
                    "sent": "Do you think a little AI can help on this kind of problem in connecting people excuse me, results to the people who need them.",
                    "label": 0
                },
                {
                    "sent": "That's that's where I think we can make a contribution.",
                    "label": 0
                }
            ]
        },
        "clip_9": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "When I talked about we have much more knowledge about cancer.",
                    "label": 0
                },
                {
                    "sent": "Today, we understand concert cancer to fairly deep level in terms of interactomes of jeans with other genes with proteins, proteins with proteins.",
                    "label": 0
                },
                {
                    "sent": "We have signaling diagrams such as this one.",
                    "label": 0
                },
                {
                    "sent": "Much of what we know is probably wrong or incomplete, but we know things and here's a couple of cancer pathways that are responsible for a large number of melanomas.",
                    "label": 0
                },
                {
                    "sent": "And I'm on the left.",
                    "label": 0
                },
                {
                    "sent": "The yellow pathway is a map kinase pathway.",
                    "label": 0
                },
                {
                    "sent": "It's the one that makes the gas pedal stick on so.",
                    "label": 0
                },
                {
                    "sent": "The cells proliferate and on the left my left and my right right.",
                    "label": 0
                },
                {
                    "sent": "Here is the PI3 pathway in blue which is a brake pedal supposed to make the cells either rest of the cell cycle or destroy themselves if they're going out of control.",
                    "label": 0
                },
                {
                    "sent": "The BRAF pathway gene at the top of the map kinase pathway is implicated in about 60 or 65% of melanomas, and just recently there's been a drug that's been developed for it.",
                    "label": 0
                },
                {
                    "sent": "So we can, in a very targeted way, find the mutation and hit it and it'll arrest those cancers.",
                    "label": 0
                },
                {
                    "sent": "They'll melt away.",
                    "label": 0
                },
                {
                    "sent": "The problem is that cancer is smart and it will find ways compens, atory mechanisms, and then you know some of the surviving clones.",
                    "label": 0
                },
                {
                    "sent": "Pi 3K might might mutate, so take the brakes off and we've got to hit that too.",
                    "label": 0
                },
                {
                    "sent": "Unfortunately, there's just now a drug that's coming into trials for being able to do that, so the ability to be able to analyze cancer at this causal level.",
                    "label": 0
                },
                {
                    "sent": "And be able to place bets by taking drugs and then capture the learnings and use that not just to treat the patient but to be able to improve our understanding of whether this causal model is right is the.",
                    "label": 0
                }
            ]
        },
        "clip_10": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Breakthrough and leads us to the possibility of trying to treat cancer to win the war on cancer in a different way, which is 1 patient at a time.",
                    "label": 0
                }
            ]
        },
        "clip_11": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "So the basic idea is to do what I wanted to do for me to be able to take for each patient, take all of the knowledge and resources in the world, and try to understand what it is that's the best possible treatment for that patient at that moment in time.",
                    "label": 0
                },
                {
                    "sent": "Then apply the patient, apply the treatment, and see how the patient does and capture the learnings not just over that patient, but overall patients in order to drive the field forward in general.",
                    "label": 0
                },
                {
                    "sent": "So that's the paradigm, and here's basically how it works.",
                    "label": 0
                },
                {
                    "sent": "I think about this is taking the 15 years in the billion dollars and shrinking that down to the time and dollars that individual patient might have.",
                    "label": 0
                }
            ]
        },
        "clip_12": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "So if we're going to take 15 years and shrink it down to a month or two, we're going to have to make not incremental improvements, but major.",
                    "label": 0
                },
                {
                    "sent": "You know, slices, slashes to this timeline then.",
                    "label": 0
                }
            ]
        },
        "clip_13": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "1st is to get rid of clinical trials because they really don't make sense in heterogeneous diseases like cancer.",
                    "label": 0
                }
            ]
        },
        "clip_14": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Replace them with deep genomic analysis of individual patients tumors.",
                    "label": 0
                }
            ]
        },
        "clip_15": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "And then the second thing we're going to have to do is to.",
                    "label": 0
                },
                {
                    "sent": "We don't have time to develop new drugs, so we're going to have to work with the drugs that we that we have on hand.",
                    "label": 0
                },
                {
                    "sent": "But that's actually a much bigger space than it appears.",
                    "label": 0
                },
                {
                    "sent": "There are 5000 drugs that have been approved by the FDA and similar organizations around the world.",
                    "label": 0
                },
                {
                    "sent": "Not to mention the investigational agents that are currently in trial.",
                    "label": 0
                }
            ]
        },
        "clip_16": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "And many of these drugs we only are, we don't even have the vaguest idea what the mechanisms of action are for those drugs.",
                    "label": 0
                },
                {
                    "sent": "Even aspirin, right?",
                    "label": 0
                },
                {
                    "sent": "We're continuing to find new uses for it, so the probabilities are pretty good that if we apply computational and systems biology.",
                    "label": 0
                }
            ]
        },
        "clip_17": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Define the match.",
                    "label": 0
                }
            ]
        },
        "clip_18": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "For that patient, against some drugs in our in our Armor Atom either used as intended or used off label or used in cocktails.",
                    "label": 0
                }
            ]
        },
        "clip_19": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "And then when we find something that works, we can test it on other patients and see how many others it works for.",
                    "label": 0
                }
            ]
        },
        "clip_20": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "And ultimately find subclasses of patients who respond to particular therapies.",
                    "label": 0
                },
                {
                    "sent": "So we have the blue patients and the green patients.",
                    "label": 0
                },
                {
                    "sent": "They respond to their respective colored pills, and that's what we're trying to do.",
                    "label": 0
                }
            ]
        },
        "clip_21": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Someday we'll have it all mapped out.",
                    "label": 0
                },
                {
                    "sent": "Will have what are called treatment guidelines, which are basically a decision tree where a patient comes in, gets their tumor tested, and depending on the particular mutations that they have, can get treated with the right drugs.",
                    "label": 0
                },
                {
                    "sent": "Unfortunately, there's a large part of the space which is currently unpopulated, unexplored, and that's the opportunity that we have and the challenge that we have is to fill out that space one patient at a time.",
                    "label": 0
                }
            ]
        },
        "clip_22": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "So I'm going to next talk about how we're doing that, and there are other people who are doing this.",
                    "label": 0
                },
                {
                    "sent": "I'm going to 1st talk about collaborative one which is a personalized oncology research service that I started with my colleagues, mainly Raffaelle era collaborates.",
                    "label": 0
                },
                {
                    "sent": "And then I'm going to talk about Cancer Commons, which is a rapid learning community, the goal of which is to be able to capture the learnings from every cancer patient in order to be able to rapidly drive the field.",
                    "label": 0
                }
            ]
        },
        "clip_23": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "So collaborates one starts with the patient and their doctor patient goes in and gets a biopsy or surgery and we have some tumor specimens.",
                    "label": 0
                },
                {
                    "sent": "We want to apply deep by genomic analysis, and I'm talking about genome wide snip, copy number, expression analysis, even sequencing, which is becoming the prices are imploding right?",
                    "label": 0
                },
                {
                    "sent": "It used to cost $1,000,000 five.",
                    "label": 0
                },
                {
                    "sent": "$100,000 is 5 years ago $50,000.",
                    "label": 0
                },
                {
                    "sent": "Today, $5000 next year, I mean the world isn't even recognizing what's happening on the imploding price curve.",
                    "label": 0
                },
                {
                    "sent": "We've got to be ready for that.",
                    "label": 0
                },
                {
                    "sent": "Get the deep analysis of the tumor.",
                    "label": 0
                },
                {
                    "sent": "Do the analysis at the level of the wiring diagram that I talked about earlier.",
                    "label": 0
                },
                {
                    "sent": "Make a recommendation for that patient feedback in a report to the Doctor and then it either works or it doesn't work.",
                    "label": 0
                },
                {
                    "sent": "If it doesn't work, we have a new data point and it's not a data point in a mouse.",
                    "label": 0
                },
                {
                    "sent": "It's not even one data point, it's thousands of data points from this genome wide analysis.",
                    "label": 0
                },
                {
                    "sent": "Go back and try to understand now more about that that space that.",
                    "label": 0
                }
            ]
        },
        "clip_24": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Wasn't filled in, and of course doing this over multiple patients gives us a chance to really analyze and understand and do learning.",
                    "label": 0
                },
                {
                    "sent": "So the interesting questions of course occur with the outliers, but one or two patients who responded when no one else did.",
                    "label": 0
                },
                {
                    "sent": "Again, what disease did these patients have that we've already cured or the patients who didn't respond to go back to the scientists on whose recommendations we based the treatment plan in the 1st place and ask what did you not understand about?",
                    "label": 0
                },
                {
                    "sent": "But disease, or about the mechanism of action of the drugs in order to have led to this result, and what can you now learn from the new data that we have?",
                    "label": 0
                },
                {
                    "sent": "The result of all this learning, we're trying to capture in a reference model, which is basically a way to populate out this tree that I showed you the reference model.",
                    "label": 0
                }
            ]
        },
        "clip_25": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Here's a picture of reference model for Melanoma.",
                    "label": 0
                },
                {
                    "sent": "As it stands today, there are a set of subtypes of Melanoma, each of which corresponds to a mutation or a combination of mutations tying back to the pathways, and each of these subtypes are actionable in the sense that there exists a clear an essay in a Cle approved laboratory that can be used to determine if a patient is in or out of that subtype, and at least one rational therapy that could be applied.",
                    "label": 0
                },
                {
                    "sent": "These don't have to be proved in clinical trials by no means, but there has to be.",
                    "label": 0
                },
                {
                    "sent": "Rational argument, that said, if the patient has this biology, this drug gotta work.",
                    "label": 0
                },
                {
                    "sent": "And then the goal is to do some some carefully planned experiments, namely patients.",
                    "label": 0
                },
                {
                    "sent": "Come in.",
                    "label": 0
                },
                {
                    "sent": "We find out what subtype there in we give them one of the approved therapies.",
                    "label": 0
                },
                {
                    "sent": "We captured the learnings.",
                    "label": 0
                },
                {
                    "sent": "Some patients are going to respond, some won't, and that's going to inevitably lead to splitting those subtypes.",
                    "label": 0
                },
                {
                    "sent": "So this list that you see here is the seed list that was created by talking to a lot of experts and then doing a meta analysis of the research literature in the data.",
                    "label": 0
                },
                {
                    "sent": "And there are 10 of them.",
                    "label": 0
                },
                {
                    "sent": "In fact, the bottom one has already dropped off.",
                    "label": 0
                },
                {
                    "sent": "There's only nine, but I I'm pretty sure in a year or two we're going to have 20 or 30 or 40.",
                    "label": 0
                },
                {
                    "sent": "I don't know how many and the interesting thing is that some of those subtypes are going to look a lot like subtypes in other cancers that are not Melanoma.",
                    "label": 0
                },
                {
                    "sent": "And that's where we're going to be able to get the the cross learn.",
                    "label": 0
                }
            ]
        },
        "clip_26": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "To happen.",
                    "label": 0
                },
                {
                    "sent": "So I'm now going to talk about Cancer Commons, which is a grand experiment to be able to take the learnings from collaborate one and everyone else is working in personalized oncology, which is a field that is really beginning to take off.",
                    "label": 0
                },
                {
                    "sent": "It's at the very, very kind of leading edge of the innovation curve and.",
                    "label": 0
                }
            ]
        },
        "clip_27": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "Basically, the goal is in this rapid learning community to give each patient the best possible treatment for them at this moment in time, capture the learnings, analyze them, try to do.",
                    "label": 1
                },
                {
                    "sent": "Incorporate those learnings back into the into the causal models and try to drive the field forward in this way.",
                    "label": 1
                },
                {
                    "sent": "So cancer Commons is not only that community, but a platform for real time translation.",
                    "label": 0
                },
                {
                    "sent": "ULL research and cancer on which this community can collaborate with each other and the community.",
                    "label": 0
                },
                {
                    "sent": "Includes importantly, not just doctors and researchers, but patients and all of the ecosystem of service providers that are needed in order to be able to get them to do this guerrilla war.",
                    "label": 0
                },
                {
                    "sent": "This aggressive style of end of 1 research.",
                    "label": 0
                }
            ]
        },
        "clip_28": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "The Cancer Commons platform is lives in the cloud.",
                    "label": 0
                },
                {
                    "sent": "It's very scalable and we've used it for building communities at many different scales, all of which are connected.",
                    "label": 0
                },
                {
                    "sent": "So if used it first to implement collaborates one, the service I just talked about and the important thing there is that this is a completely virtual service in the sense that I don't have any laboratories.",
                    "label": 0
                },
                {
                    "sent": "The closest thing I have is a lab is my kitchen, but we do outsource everything to different service providers in that ecosystem.",
                    "label": 0
                },
                {
                    "sent": "This.",
                    "label": 0
                },
                {
                    "sent": "He speaks of my ecommerce background.",
                    "label": 0
                }
            ]
        },
        "clip_29": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "We've also used it to cook together a community of researchers who were involved in helping to develop the Melanoma reference model, and we're now putting collaborative one together with this reference model so that we can use the reference model to guide the initial treatment of patients and then when patients don't respond to take their specimens and put it through the very same research process that was used to capture the model in the first place.",
                    "label": 0
                }
            ]
        },
        "clip_30": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "We are now hoping to move forward and use this same platform to connect many groups, like the group that was involved in creating the initial reference model in order to be able to explore different combinations of Melanoma therapies.",
                    "label": 0
                },
                {
                    "sent": "Different combinations of investigational agents which are in trial which is truly revolutionary because drug companies traditionally have not allowed their drugs in trial to be tested in combination, but like aids, it's often the case that these therapies won't work as monotherapies.",
                    "label": 0
                },
                {
                    "sent": "They have to be used in combination, so we're trying to put together a community built on the Cancer Commons platform so that when a patient comes in, they will get routed to the trial.",
                    "label": 0
                },
                {
                    "sent": "That's most likely to help them, and similarly, the trial will have patients that will be most likely to inform.",
                    "label": 0
                },
                {
                    "sent": "So this is actually quite revolutionary.",
                    "label": 0
                },
                {
                    "sent": "And then one step up from this, the entire Melanoma community is.",
                    "label": 0
                }
            ]
        },
        "clip_31": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Is simply one node on cancer Commons, and so we have similar communities that we're planning to build for other cancers, and these will all be connected.",
                    "label": 0
                },
                {
                    "sent": "And the interesting thing is that there are many, many opportunities are already emerging to be able to demonstrate the cross learnings between these communities.",
                    "label": 0
                },
                {
                    "sent": "So, for example, there's a drug called Gleevec, which was a wonder drug for a certain type of leukemia, chronic myelogenous leukemia.",
                    "label": 0
                },
                {
                    "sent": "But basically made that disease something one could live with for a very long time.",
                    "label": 0
                },
                {
                    "sent": "It turned out that 3% of melanomas expressed a mutation that that drug happened to hit.",
                    "label": 0
                },
                {
                    "sent": "Who would have guessed.",
                    "label": 0
                },
                {
                    "sent": "Similarly, the drug that I talked about, the B RAF inhibitor, and that I was talking about earlier for Melanoma may be applicable to the 7% of colorectal cancers that Express B RAF mutations.",
                    "label": 0
                },
                {
                    "sent": "We don't know that yet, and there are many, many mutations that are shared across the solid tumors.",
                    "label": 0
                },
                {
                    "sent": "In the GI tract and the long so this is an opportunity to do the kind of cross learning that requires the kind of thinking and applications that we can do in this Community.",
                    "label": 0
                },
                {
                    "sent": "So that's cancer Commons.",
                    "label": 0
                }
            ]
        },
        "clip_32": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "And I would now like to talk about the AI opportunities and challenges.",
                    "label": 0
                }
            ]
        },
        "clip_33": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "So re framing things from an AI perspective.",
                    "label": 0
                },
                {
                    "sent": "What we're talking about is a gigantic search over the opportunity space of targets and leads, and that search is guided by knowledge.",
                    "label": 0
                },
                {
                    "sent": "Alot of knowledge about cancer, biology about drugs about clinical response tests, assays.",
                    "label": 0
                },
                {
                    "sent": "All of those things.",
                    "label": 0
                },
                {
                    "sent": "The problem is that the knowledge is largely uncertain.",
                    "label": 0
                },
                {
                    "sent": "Still, is large gaps in the knowledge.",
                    "label": 0
                },
                {
                    "sent": "Complete, uncertain, much of it is no doubt wrong.",
                    "label": 0
                },
                {
                    "sent": "And So what we have to do is use the experiments on patients ethical experiments.",
                    "label": 0
                },
                {
                    "sent": "Remember 'cause every patient has to get the best treatment for them personally, but to gradually start to fill in these gaps.",
                    "label": 0
                }
            ]
        },
        "clip_34": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "By doing adaptive planning to be able to look at the questions that we're trying to answer and then go back and try to use patients in an ethical way to run these experiments, capture, learn.",
                    "label": 0
                }
            ]
        },
        "clip_35": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Things use the learnings to infer what we can about the causal nature of cancer and the mechanisms of action of the drugs, and then generalize from each patient.",
                    "label": 0
                }
            ]
        },
        "clip_36": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Many other patients in order to be able to drive the field forward.",
                    "label": 0
                },
                {
                    "sent": "Now, of course, there's much too big a gap between patients and the knowledge ball over there, so we've got to have intermediate levels of learning.",
                    "label": 0
                }
            ]
        },
        "clip_37": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "And of course, we've talked about one so far, which is the reference model, which is a very nice, crisp, adaptive problem where the goal is to be able to continually improve prediction.",
                    "label": 0
                }
            ]
        },
        "clip_38": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "But there are many, many, many other levels of knowledge, and these are some of the levels that are involved in the collaborative.",
                    "label": 0
                },
                {
                    "sent": "One process.",
                    "label": 0
                },
                {
                    "sent": "For those of you in the back pathway analysis mechanism of analysis, what do these pathways have to do with particular known cancer mechanisms?",
                    "label": 1
                },
                {
                    "sent": "Using that to identify targets, drugs, picking clinical trials, and so forth?",
                    "label": 0
                },
                {
                    "sent": "And we've got learning to do on every one of these levels every day with every patient.",
                    "label": 0
                }
            ]
        },
        "clip_39": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "So the generalization is basically that each level generates hypothesis that can be then used that can then be tested at the next level down, as is traditional in a hierarchical learning system, and I think that hierarchical Bayes is a very nice way to formulate this problem because all the knowledge is probabilistic at every single level.",
                    "label": 0
                }
            ]
        },
        "clip_40": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "So in the time remaining, I'm going to focus on some specific challenges for and opportunities and challenges for this community in three areas.",
                    "label": 0
                },
                {
                    "sent": "Knowledge management, hierarchical planning and learning, and generalization.",
                    "label": 0
                },
                {
                    "sent": "1st in terms of now.",
                    "label": 0
                }
            ]
        },
        "clip_41": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Image management I've already said that cancer curing cancer, treating cancer involves a lot of knowledge, and these are.",
                    "label": 0
                },
                {
                    "sent": "There's a very small fraction of the knowledge that's available just on the Internet and I want to give you a scale, an idea for the scale of this knowledge Pub Med, which is major resource from the National Library of Medicine, has 20,000,000 abstracts of medical literature in it.",
                    "label": 0
                },
                {
                    "sent": "About 3 million of those who specifically about cancer.",
                    "label": 0
                },
                {
                    "sent": "But the answers don't necessarily come from that.",
                    "label": 0
                },
                {
                    "sent": "The answers may come from, for example, literature on metabolism, because cancer screws up all kinds of processes within cells, and if they may provide the clue about how to do introduction, the gene expression omnibus is a public database of gene expression data.",
                    "label": 0
                },
                {
                    "sent": "There is 450,000.",
                    "label": 0
                },
                {
                    "sent": "Experiments that are documented, their gene expression, and sometimes the clinical annotation that goes with them.",
                    "label": 0
                },
                {
                    "sent": "That was last time I looked a few days ago, this grows by hundreds of experiments daily.",
                    "label": 0
                },
                {
                    "sent": "Clinicaltrials.gov has nearly 100,000 trials ongoing at any moment in time.",
                    "label": 0
                },
                {
                    "sent": "And about 40% of those are cancer.",
                    "label": 0
                },
                {
                    "sent": "And ASCO is where the cancer trials American Society of clinical oncology.",
                    "label": 0
                },
                {
                    "sent": "It's a conference, much like this one, just larger where the trials get reported each year.",
                    "label": 0
                },
                {
                    "sent": "And this is truly the front lines.",
                    "label": 0
                },
                {
                    "sent": "And I want to.",
                    "label": 0
                }
            ]
        },
        "clip_42": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "You are a report from the front lines of ASCO a month ago.",
                    "label": 0
                },
                {
                    "sent": "I went to ASCO 2010, which is in Chicago.",
                    "label": 0
                },
                {
                    "sent": "There are 30,000 people at that conference.",
                    "label": 0
                },
                {
                    "sent": "The plenary Hall is at least as long as this one and at least as wide.",
                    "label": 0
                },
                {
                    "sent": "It's the biggest room I've ever seen.",
                    "label": 0
                },
                {
                    "sent": "It's not like a sports stadium where you can actually see the players in the back of the room.",
                    "label": 0
                },
                {
                    "sent": "You can see a pinpoint of the guy up in the front giving the talk and then hundreds of screens scattered through the room.",
                    "label": 0
                },
                {
                    "sent": "So you gotta have a visceral understanding.",
                    "label": 0
                },
                {
                    "sent": "So 20 ring.",
                    "label": 0
                },
                {
                    "sent": "Circus 4000 abstracts are presented in four days, of which about six of them make the plenary, so those are.",
                    "label": 0
                },
                {
                    "sent": "Those are the ones that are considered practice changing and those are the ones you can read about in the New York Times.",
                    "label": 0
                },
                {
                    "sent": "But there are 500 or 1000 others that might be lifesaving for some patient.",
                    "label": 0
                },
                {
                    "sent": "If there was only a way to be able to get that information and put it in front of the patient and dock at the right time.",
                    "label": 0
                },
                {
                    "sent": "So I'll ask my question again, do you think a little AI can help?",
                    "label": 0
                }
            ]
        },
        "clip_43": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "There's another issue that comes up.",
                    "label": 0
                },
                {
                    "sent": "We talked about a few slides ago.",
                    "label": 0
                },
                {
                    "sent": "I said there was this drug for leukemia that helped 3% of.",
                    "label": 0
                },
                {
                    "sent": "Melanoma patients it took nearly two decades to be able to take that knowledge and transfer it and then be able to connect the dots to be able to figure that out.",
                    "label": 0
                },
                {
                    "sent": "So the result that said Gleevec has major response for Melanoma patients who express AC kit mutation was published.",
                    "label": 0
                },
                {
                    "sent": "I believe in 1998 by in 2008 by a friend of mine Steven Hoodie, but in 1991, Ruth Alabama, who was a pioneering AI researcher, sequencing things by hand.",
                    "label": 0
                },
                {
                    "sent": "Figured out that seek it was a mutation that drove some small number of melanomas.",
                    "label": 0
                },
                {
                    "sent": "She did that work at Yell, so that was 1991 in 1998.",
                    "label": 0
                },
                {
                    "sent": "Excuse me.",
                    "label": 0
                },
                {
                    "sent": "A group run, run, run by Brian Druker created a drug at the time it was called SDI.",
                    "label": 0
                },
                {
                    "sent": "471 I believe drug that was later to become Gleevec.",
                    "label": 0
                },
                {
                    "sent": "Was designed to address a particular a different mutation that was called.",
                    "label": 0
                },
                {
                    "sent": "It was a Fusion gene that happened when two pieces or chromosome broke off and came together and created an uncle Gene, a gene that causes cancer.",
                    "label": 0
                },
                {
                    "sent": "And this drug was very effective against that Fusion gene, so there's nothing Ruth, Alabama could do.",
                    "label": 0
                },
                {
                    "sent": "In 1991, there was no drug.",
                    "label": 0
                },
                {
                    "sent": "There's nothing anyone can do.",
                    "label": 0
                },
                {
                    "sent": "In 1998 there was a drug for this Fusion gene called BCR ABL.",
                    "label": 0
                },
                {
                    "sent": "But then in 2000 or thereabouts Druker the same group working in a different cancer, gastrointestinal stromal tumors discovered that this drug for some reason happened to also bind to and inhibit seek it.",
                    "label": 0
                },
                {
                    "sent": "Well, there was still some dots to be connected because it wasn't till three years later the group in Italy inspired by a letter to the editor and an obscure Italian Journal that no one had ever seen.",
                    "label": 0
                },
                {
                    "sent": "That said, you know, maybe we should try Gleevec on the Melanomas Express ticket.",
                    "label": 0
                },
                {
                    "sent": "He connected a few dots in his head and so that led to the work that Stephen Hodi finally published in 2008 at ASCO.",
                    "label": 0
                },
                {
                    "sent": "So nearly two decades went.",
                    "label": 0
                }
            ]
        },
        "clip_44": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Bye to connect three dots.",
                    "label": 0
                },
                {
                    "sent": "Now this is something if you're serendipitous enough, you overhear something in that cocktail lounge or something that the conference science works this way, but it is unacceptable for it to work this way in cancer.",
                    "label": 0
                },
                {
                    "sent": "There are too many lives at stake, and it's easy enough to connect 3.",
                    "label": 0
                }
            ]
        },
        "clip_45": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "That's, but this is the size of the knowledge base that we're dealing with.",
                    "label": 0
                },
                {
                    "sent": "These happen to be some of the databases that people involved in the Semantic Web project are trying to connect up, and the ones and magenta.",
                    "label": 1
                },
                {
                    "sent": "Here are the ones specifically relevant to this project that I'm trying to do, and as I said, just one of them.",
                    "label": 0
                },
                {
                    "sent": "Pub Med has 20,000,000 abstracts in it.",
                    "label": 0
                },
                {
                    "sent": "So we need some AI here.",
                    "label": 0
                }
            ]
        },
        "clip_46": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "It's not that hard to do some capture some low hanging fruit here.",
                    "label": 0
                },
                {
                    "sent": "Back in 2003, Alan Rappaport Gov, who did a company called Neuron Data, which some of you may remember from earlier days and I was at Carnegie Student and I had a different company called Medstory put together a simple application for ASCO.",
                    "label": 0
                }
            ]
        },
        "clip_47": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "In which we got people submitting abstracts in breast cancer to fill out a form something like this, which is akin to the reference model.",
                    "label": 1
                },
                {
                    "sent": "What subtype of breast cancer were there?",
                    "label": 0
                },
                {
                    "sent": "And there are only three subtypes.",
                    "label": 0
                },
                {
                    "sent": "Back then, there wasn't very complicated, but based on the author filling this out.",
                    "label": 0
                },
                {
                    "sent": "Then when I researcher or doctor came in and said what trials are relevant to my patient instead of having to thumb through 4000 pages of Bible paper, you know one page per 4004 thousand abstracts.",
                    "label": 0
                },
                {
                    "sent": "They could look it up, and this was we actually ran a clinical trial and whether people would use this.",
                    "label": 0
                },
                {
                    "sent": "And 95% of the authors voluntarily filled this out when they were submitting the application.",
                    "label": 1
                },
                {
                    "sent": "In 70% of people looking up trials used it because they felt it would be helpful.",
                    "label": 0
                },
                {
                    "sent": "This is a big success and I'm basically building on this now.",
                    "label": 0
                },
                {
                    "sent": "For as the human interface the user into.",
                    "label": 0
                }
            ]
        },
        "clip_48": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Base for cancer Commons.",
                    "label": 0
                },
                {
                    "sent": "So if you can imagine just adding some buttons to the side of this where you fill out whatever it is about your patient and then click a button and be.",
                    "label": 0
                }
            ]
        },
        "clip_49": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Able to find out what the treatment guidelines aren't wearing that big decision tree.",
                    "label": 0
                },
                {
                    "sent": "You should be not looking through these decision trees themselves can run 200 pages or more.",
                    "label": 0
                }
            ]
        },
        "clip_50": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Or what clinical trials are available?",
                    "label": 0
                },
                {
                    "sent": "I don't mean going through all the clinical trials, finding the clinical trials that are best for that patient.",
                    "label": 0
                }
            ]
        },
        "clip_51": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Or because the information is computational, once you've captured it in that.",
                    "label": 0
                },
                {
                    "sent": "In that form you know what subtype the cancer has.",
                    "label": 0
                },
                {
                    "sent": "We can build little applications like this, which is a mock up of an application that we're building for the launch of Cancer Commons, which will be in a month or so.",
                    "label": 0
                },
                {
                    "sent": "By the way you heard about it here first, in which you click in the mutations that the patient has, and it gives you precisely the right trials for that patient.",
                    "label": 0
                },
                {
                    "sent": "So simple stuff from an AI perspective, but very, very in.",
                    "label": 0
                }
            ]
        },
        "clip_52": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Portent so the challenge for this community is to organize the world's knowledge of cancer, biology and therapeutics and make it useful for the people who need it.",
                    "label": 0
                },
                {
                    "sent": "Challenge one.",
                    "label": 0
                }
            ]
        },
        "clip_53": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "The second area we're going to talk about is planning and we've talked about that a little bit and already.",
                    "label": 0
                },
                {
                    "sent": "But the key is that there are two types of planning.",
                    "label": 0
                },
                {
                    "sent": "The first is treatment planning for an individual, and there the goal is first of all to find something that will work for that patient to make sure that you get enough shots on goal in the hockey sense, because giving a patient one treatment may disqualify them for a second trial, for example.",
                    "label": 0
                },
                {
                    "sent": "So you want to look at all the possibility space for that patient given the best possible shot.",
                    "label": 0
                },
                {
                    "sent": "For where they are and what's available that moment in time, and then when you start getting into combination therapies, things get more tricky because you have to deal with what order the therapies are given in with dosing and so forth.",
                    "label": 0
                },
                {
                    "sent": "So it's an interesting little planning problem subject to some real world constraints about how much time the patient has, how much specimen you have to work with, how much dollars you have to do, tests you always do more tests, but they are often limited in practice.",
                    "label": 0
                },
                {
                    "sent": "And the second type of planning puts the bigger context around this of as a research field.",
                    "label": 0
                },
                {
                    "sent": "What hypothesis do we need to validate we have different models of how to treat cancer in different drugs for each of those models, and we need to be able to learn from the ethical experiments that we're running on patients in order to be able to drive this learning.",
                    "label": 0
                },
                {
                    "sent": "And I want to give you a sense about the possibilities for what can be done if there was a way to coordinate planning over a research field.",
                    "label": 0
                },
                {
                    "sent": "Now I don't know that there is such a way.",
                    "label": 0
                },
                {
                    "sent": "Except in limited contexts, where there's a Funding Agency who kind of will insist on it because doctors will go and do what they should do what they want to do for each patient.",
                    "label": 0
                },
                {
                    "sent": "But if there were.",
                    "label": 0
                }
            ]
        },
        "clip_54": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Away again thinking about cancer as a giant search the way things are done today is that individual CYA.",
                    "label": 0
                }
            ]
        },
        "clip_55": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "This pursue, you know.",
                    "label": 0
                },
                {
                    "sent": "Interesting opportunities as they see them and they too often reach dead ends and then they don't publish them because there was nothing positive to report.",
                    "label": 0
                },
                {
                    "sent": "So other people are doomed to keep repeating that and then they go off and start exploring somewhere else.",
                    "label": 0
                },
                {
                    "sent": "But suppose there was a way to coordinate the research so that we could look at an entire family of.",
                    "label": 0
                }
            ]
        },
        "clip_56": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "If Lee targets and leads and basically say, let's do.",
                    "label": 0
                }
            ]
        },
        "clip_57": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Prove them all at once so we can wipe out a whole part of that tree.",
                    "label": 0
                },
                {
                    "sent": "And now let's turn things on its head like we were talking.",
                    "label": 0
                }
            ]
        },
        "clip_58": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "To start with the patient and wipe out all the things that are not relevant to that patient now.",
                    "label": 0
                }
            ]
        },
        "clip_59": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "We have a planning problem which is cut down the size.",
                    "label": 0
                },
                {
                    "sent": "That's the opportunity that I would like to think about how to do research planning coordinated with treatment planning.",
                    "label": 0
                },
                {
                    "sent": "For those of you interested in hierarchical planning, you can find him more.",
                    "label": 0
                }
            ]
        },
        "clip_60": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "Very interesting and challenging problem.",
                    "label": 0
                },
                {
                    "sent": "So my second challenge is to be able to adaptively plan thousands of individual treatment experiments while maximizing the learnings from them for the uncertainties that you have in your model.",
                    "label": 1
                },
                {
                    "sent": "Now, as I've already mentioned, that the ability to be able to tell oncologists that they should be using this or that is somewhat limited, and so for every planned experiment that when does there's going to be hundreds if not thousands of other experiments that we just need a way to be able to capture the serendipitous learnings from those.",
                    "label": 0
                }
            ]
        },
        "clip_61": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "And so the third area is learning and.",
                    "label": 0
                },
                {
                    "sent": "There are basically two types of models that we're dealing with.",
                    "label": 0
                },
                {
                    "sent": "The first very simple predictive models which may be statistical or maybe causal, but the reference model that I talked about is an example and the 2nd is deeper.",
                    "label": 0
                },
                {
                    "sent": "Causal models of tumors and drugs, and there are some very interesting work going on in the machine learning statistical AI communities for doing that, and we want to put these together in the way.",
                    "label": 0
                }
            ]
        },
        "clip_62": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Is that I talked about, so we've talked a lot about the reference model already taking the subtypes and splitting them.",
                    "label": 0
                },
                {
                    "sent": "I'm not going to say more about.",
                    "label": 0
                }
            ]
        },
        "clip_63": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "That, but when we talked about the levels of knowledge in.",
                    "label": 0
                },
                {
                    "sent": "Collaborates one way to think about this is that we want to be able to learn over all of these levels.",
                    "label": 0
                },
                {
                    "sent": "What's happening in an individual patient based on all of the knowledge that we have about cancer in general and about drugs in general and put together.",
                    "label": 0
                },
                {
                    "sent": "If you like the best possible linkage among all of these levels in terms of probability of cure that connects the actual measurements from the thousands of data points that we're capturing to what pathways we believe are active to what mechanisms we think they're driving.",
                    "label": 0
                },
                {
                    "sent": "What's the best targets?",
                    "label": 0
                },
                {
                    "sent": "The treatments?",
                    "label": 0
                },
                {
                    "sent": "What are the clinical trials?",
                    "label": 0
                },
                {
                    "sent": "Put those all together and then if it works or doesn't work to be able to go back and be able to drive learning at every single one of these levels.",
                    "label": 0
                }
            ]
        },
        "clip_64": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Which brings me to my third challenge.",
                    "label": 0
                },
                {
                    "sent": "For those of you involved in learning, this is what it's about to be able to capture and integrate what we learn from every single patient in order to be able to drive our knowledge and then generalize so we can help as many other patients as possible.",
                    "label": 0
                }
            ]
        },
        "clip_65": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "Which brings me to the end of the story.",
                    "label": 0
                },
                {
                    "sent": "We've talked about cancer from the perspective of an AI researcher, Internet entrepreneur and Survivor.",
                    "label": 0
                },
                {
                    "sent": "We've talked about a new paradigm where the goal is to be able to cure cancer one patient at a time, and we've talked about opportunities and challenges for using AI in order to be able to drive this work for much of the 40 years of the war on cancer, the AI community has been driven by grand challenges, none more prominent than chess.",
                    "label": 1
                },
                {
                    "sent": "And I would like to propose a new grand challenge.",
                    "label": 0
                },
                {
                    "sent": "Hopefully not for the next 40 years.",
                    "label": 0
                },
                {
                    "sent": "How about for the next 5?",
                    "label": 0
                }
            ]
        },
        "clip_66": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Here's, which is to kick cancers.",
                    "label": 0
                },
                {
                    "sent": "You know what?",
                    "label": 0
                },
                {
                    "sent": "The.",
                    "label": 0
                },
                {
                    "sent": "Cancer is a lot harder than chess and so many ways to begin with it requires we have incomplete knowledge with the game, requires a lot of knowledge.",
                    "label": 0
                },
                {
                    "sent": "Much of what we know is incomplete or wrong, and so we've got to fix that.",
                    "label": 0
                },
                {
                    "sent": "So for all of you who are interesting, interested in knowledge management, I have given you your challenges.",
                    "label": 0
                },
                {
                    "sent": "We've got to be able to plan thousands of adaptive experiments, except many of these experiments that will give you optimal knowledge about the uncertainties or either unethical.",
                    "label": 0
                },
                {
                    "sent": "Or you can't do them because you can't get the drugs to do them, which really makes me sad 'cause the pharma companies won't give him to us or you don't have control over what the docs do or they're just not might be any patients available to test.",
                    "label": 0
                },
                {
                    "sent": "You know particular things.",
                    "label": 0
                },
                {
                    "sent": "Integrating learning well.",
                    "label": 0
                },
                {
                    "sent": "Can.",
                    "label": 0
                },
                {
                    "sent": "Cancer is a very widely opponent, and so if you learn something, unlike in chess cancers, quite capable of.",
                    "label": 0
                },
                {
                    "sent": "Changing the rules on you and developing new mutations that you didn't know about, so you gotta deal with that too.",
                    "label": 0
                },
                {
                    "sent": "And finally, there are no grandmasters and cancer, unlike chess, you play with cancer, you're going to lose most of the time so.",
                    "label": 0
                },
                {
                    "sent": "I, I think that cancer Commons presents a unique opportunity by putting researchers, patients, and physicians on the same platform to be able to capture an extraordinary amount of data and try to close that translation a loop in real time.",
                    "label": 0
                },
                {
                    "sent": "I really need your help.",
                    "label": 0
                },
                {
                    "sent": "I'm saying this very, very sincerely if you're looking for a good place to do applications of AI or even basic research in AI, because some of that's needed here.",
                    "label": 0
                }
            ]
        },
        "clip_67": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Please get in touch with me.",
                    "label": 0
                },
                {
                    "sent": "JMT at collaborative.com and you know, I can.",
                    "label": 0
                },
                {
                    "sent": "I can if you want some one more incentive, unlike cancer.",
                    "label": 0
                },
                {
                    "sent": "Excuse me, I'm like chess.",
                    "label": 0
                },
                {
                    "sent": "Cancer has the NIH, which puts a billion dollars a year into trying to cure it.",
                    "label": 0
                },
                {
                    "sent": "And there are 10,000,000 lives at stake.",
                    "label": 0
                },
                {
                    "sent": "Let's go, let's go.",
                    "label": 0
                },
                {
                    "sent": "Do some good thank you very very much.",
                    "label": 0
                }
            ]
        }
    }
}